These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12097807)

  • 1. Impact on Thai psychiatrists of passive dissemination of a clinical practice guideline on prescribing attitudes in treatment-resistant schizophrenia.
    Udomratn P; Srisurapanont M
    Neuropsychobiology; 2002; 45(4):186-90. PubMed ID: 12097807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which neuroleptic would psychiatrists take for themselves or their relatives?
    Steinert T
    Eur Psychiatry; 2003 Feb; 18(1):40-1. PubMed ID: 12648897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [PRESCRIPTION PATTERNS IN THE TREATMENT OF SCHIZOPHRENIA].
    Leiderman EA; Lorenzo L
    Vertex; 2015; 26(119):11-6. PubMed ID: 26323108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics.
    Samalin L; Garnier M; Auclair C; Llorca PM
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A national study of psychiatrists' professional activities.
    Dorwart RA; Chartock LR; Dial T; Fenton W; Knesper D; Koran LM; Leaf PJ; Pincus H; Smith R; Weissman S
    Am J Psychiatry; 1992 Nov; 149(11):1499-505. PubMed ID: 1357992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study.
    Nakamura T; Furihata R; Hasegawa N; Kodaka F; Muraoka H; Ichihashi K; Ochi S; Numata S; Tsuboi T; Makinodan M; Iida H; Onitsuka T; Kashiwagi H; Takeshima M; Hashimoto N; Nagasawa T; Usami M; Yamagata H; Takaesu Y; Miura K; Matsumoto J; Ohi K; Yamada H; Hori H; Inada K; Watanabe K; Hashimoto R; Yasui-Furukori N
    BMC Psychiatry; 2024 May; 24(1):399. PubMed ID: 38807065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription preferences in antipsychotics and attitude towards the pharmaceutical industry in Belgium.
    Cleymans S; Morrens M; Bervoets C
    J Med Ethics; 2017 Jun; 43(6):359-363. PubMed ID: 27895084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical decision making in antipsychotic drug choice for schizophrenia.
    Hamann J; Langer B; Leucht S; Busch R; Kissling W
    Am J Psychiatry; 2004 Jul; 161(7):1301-4. PubMed ID: 15229068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Antipsychotic Prescriptions Between Centers in Young Outpatients With Schizophrenia.
    Højlund M; Munk-Jørgensen P
    J Clin Psychopharmacol; 2017 Dec; 37(6):753-754. PubMed ID: 28891833
    [No Abstract]   [Full Text] [Related]  

  • 11. Clozapine: a review of clinical practice guidelines and prescribing trends.
    Warnez S; Alessi-Severini S
    BMC Psychiatry; 2014 Apr; 14():102. PubMed ID: 24708834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatrists' self-reported adherence to evidence-based prescribing practices in the treatment of schizophrenia.
    Young GJ; Mohr DC; Meterko M; Seibert MN; McGlynn G
    Psychiatr Serv; 2006 Jan; 57(1):130-2. PubMed ID: 16399975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
    Patel MX; Nikolaou V; David AS
    Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in the prescription of Olanzapine as a first-line treatment for first episode psychosis following the implementation of clinical practice guidelines.
    Nguyen T; Seiler N; Maguire J; Sizer H; McGorry P; Brown E; O'Donoghue B
    Schizophr Res; 2020 Jan; 215():469-470. PubMed ID: 31493968
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient, Physician and Organizational Influences on Variation in Antipsychotic Prescribing Behavior.
    Tang Y; Chang CC; Lave JR; Gellad WF; Huskamp HA; Donohue JM
    J Ment Health Policy Econ; 2016 Mar; 19(1):45-59. PubMed ID: 27084793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project.
    Ichihashi K; Hori H; Hasegawa N; Yasuda Y; Yamamoto T; Tsuboi T; Iwamoto K; Kishimoto T; Horai T; Yamada H; Sugiyama N; Nakamura T; Tsujino N; Nemoto K; Oishi S; Usami M; Katsumoto E; Yamamori H; Tomita H; Suwa T; Furihata R; Inagaki T; Fujita J; Onitsuka T; Miura K; Matsumoto J; Ohi K; Matsui Y; Takaesu Y; Hashimoto N; Iga J; Ogasawara K; Yamada H; Watanabe K; Inada K; Hashimoto R
    Neuropsychopharmacol Rep; 2020 Sep; 40(3):281-286. PubMed ID: 32602667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatrists' attitude towards the use of clozapine in the treatment of refractory schizophrenia: A nationwide survey.
    Daod E; Krivoy A; Shoval G; Zubedat S; Lally J; Vadas L; Weizman A; Reshef A; Bloch B
    Psychiatry Res; 2019 May; 275():155-161. PubMed ID: 30913436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of clozapine prescribing in a mental health service in New Zealand.
    Harrison J; Janlöv M; Wheeler AJ
    Pharm World Sci; 2010 Aug; 32(4):503-11. PubMed ID: 20526811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.
    Berkowitz RL; Patel U; Ni Q; Parks JJ; Docherty JP
    J Clin Psychiatry; 2012 Apr; 73(4):498-503. PubMed ID: 22226332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.